Fine-needle aspiration (FNA) and frozen section evaluation are traditional components of the management of thyroid lesions. Their role and usefulness are dictated by some basic facts about thyroid pathology: (a) nodules are very common; (b) they are benign in the majority of cases; and (c) the diagnosis of malignancy is primarily based on cytologic features in the case of papillary carcinoma, and on the presence of invasion of the tumor capsule or of blood vessels in the case of follicular carcinoma. The common occurrence of benign thyroid nodules mandates a cost-effective effective method for preoperative screening. Since, as already stated, the diagnosis of papillary thyroid carcinoma (by far the most common thyroid malignancy) is based on the identification of characteristic cytologic features, FNA has easily emerged in the past 30 years as the most accurate and cost-effective tool-indeed a true cornerstone-for the preoperative management of thyroid nodules. Standardized terminology to report cytologic diagnoses is highly recommended and is being implemented worldwide. Conversely, the importance of intraoperative frozen section diagnosis has been constantly decreasing over the past years, as a direct consequence of the widespread application of FNA. It may, however, be very useful in cases that are suspicious for papillary carcinoma on FNA and in selected cases with an indeterminate cytologic diagnosis.
Preoperative Thyroid Cytology
Fine-needle aspiration (FNA) is an essential procedure for the preoperative evaluation of patients with thyroid nodules. [1] [2] [3] [4] Its main role is in the triage of patients that require surgery and has succeeded in greatly reducing unnecessary thyroid surgery worldwide. 3, 4 In some cases it provides a definite diagnosis of malignancy and tumor typing, thus allowing comprehensive surgery and therapy planning in one step. 3, 4 Among thyroid nodules that undergo successful FNA, about 60% are classified cytologically as benign, whereas less than 10% are deemed malignant. 5, 6 The remaining 30% exhibit features that are not diagnostic of either benignancy or malignancy. Various diagnostic terminologies, including "atypical," "indeterminate," and "suspicious for malignancy" are used to describe them. 7, 8 These categories reflect the limitations of thyroid FNA that are inherently related to the nature of the procedure and to sampling. It is clearly difficult to compress into specific diagnostic categories the large variety of pathological conditions that can affect the thyroid gland, but several classification schemes have been developed over the years to standardize reporting and to facilitate communication. One of the most popular is the 5-tier system (Thy1-Thy5) first introduced by the British Thyroid Association/Royal College of Pathologists in 2002. Alas, in many instances local or even "personal" terminologies are employed, with no uniformity for reporting diagnoses and for the definition of specimen adequacy. 9,10 Although these local or "personal" terminologies allow for much flexibility, they also cause difficulty in communicating the clinical implications of thyroid FNA results both to the direct caregivers (endocrinologists and surgeons) and to their indirect counterparts (pathologists and radiologists). 11 The most ambitious effort to standardize this terminology in recent times is the Bethesda proposal for reporting thyroid cytopathology, the offspring of a workshop hosted by the National Cancer Institute in Bethesda, Maryland, in October 2007 and inspired by the Bethesda system for reporting cervical cytology, now widely used for reporting Pap test results. [12] [13] [14] [15] The Bethesda proposal for thyroid cytopathology recommends 6 diagnostic categories 12-15 : I. nondiagnostic or unsatisfactory (ND/UNS) II. benign III. atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) IV. follicular neoplasm or suspicious for a follicular neoplasm (FN/SFN) V. suspicious for malignancy VI. malignant An important aspect of the proposal is that each category has been linked to a specific cancer risk and therefore to an expected patient management action. The proposal also includes recommendations for ancillary studies, such as immunohistochemistry and molecular analysis. [12] [13] [14] [15] Parenthetically, it should be noted that the type of genetic alterations that occur in thyroid cancer and the very nature of the FNA samples make the latter ideally suited for molecular analysis, a tool that may significantly contribute to increase diagnostic accuracy in the not too distant future.
The Bethesda system for reporting thyroid cytopathology has been well received and is being utilized with positive results in the United States and elsewhere. [16] [17] [18] Thus, Theoharis et al 16 studied its diagnostic accuracy on a cohort of more than 3200 thyroid FNAs: 11.1% of the thyroid nodules were deemed unsatisfactory, 73.8% benign, 3% indeterminate (AUS/FLUS), 5.5% follicular neoplasm, 1.3% suspicious for malignancy, and 5.2% positive for malignancy, supporting the use of the 6-tier diagnostic approach. Although it has been argued that the AUS/FLUS category should be better defined to avoid becoming a "waste basket" diagnostic category, [19] [20] [21] we feel that its judicious use meets the needs advocated by the Bethesda system. 12, 18 Obviously, standardized reporting with specific categories should not be intended as a substitute for the interpretation of cytologic data, since numbers alone cannot and should not be used to replace a diagnostic analysis or to reduce the need for clinicopathologic correlation. Standardized reporting represents instead an aid to the pathologist to maximize the impact of FNAs on patient management. It should be used as such and always accompanied by the appropriate diagnoses, explanatory notes, and personal comments in a text format. Other existing local and national FNA reporting terms can be easily modified and "translated" into those of the Bethesda system, as done by the Royal College of Pathologists (Guidance on the reporting of thyroid cytology specimens, November 2009, http://www.rcpath.org/resources/ pdf/g089guidanceonthereportingofthyroidcytologyfinal.pdf, accessed October 29, 2010): Thy1 (Bethesda system category I-ND/UNS), Thy2 (Bethesda system category II-Benign), Thy3a (Bethesda system category III-AUS/FLUS), Thy3f
(Bethesda system category IV-FN/SFN), Thy4 (Bethesda system category V-Suspicious for malignancy), Thy5 (Bethesda system category VI-Malignant). This open attitude constitutes an important step toward a unified nomenclature, a goal that is clearly worth achieving. 20, 22 
Intraoperative Consultation
An issue related to the preoperative FNA diagnosis of thyroid nodules is that of the intraoperative frozen section evaluation, the aim of which is to provide the surgeon with information leading to immediate action at the operating table. This usually means making a choice between total thyroidectomy and lobectomy. 23 Diagnostic categories commonly used for frozen section diagnosis somewhat mirror those rendered after FNA. They include the following:
Benign thyroid nodule: Lesions with low cellularity
and predominantly large follicles; 2. Encapsulated follicular lesion/neoplasm, defer to permanent sections: Cellular lesions with no capsular or vascular invasion identified on frozen section and lack of nuclear features of papillary carcinoma on intraoperative cytology smears (follicular adenoma/follicular carcinoma); 3. Papillary carcinoma: Lesions with papillary or follicular architecture and nuclear features of papillary carcinoma on intraoperative cytology smears; 4. Follicular carcinoma: Capsular and/or vascular invasion clearly identified at the time of the intraoperative consultation; most of these cases are widely invasive tumors, often with poorly differentiated features; 5. Other tumors and tumor-like conditions: medullary carcinoma, lymphoma, anaplastic carcinoma, Riedel thyroiditis.
The number of intraoperative consultations has been steadily declining because of the accuracy of FNA in diagnosing papillary thyroid carcinoma, and the need for extensive sampling of the tumor capsule to diagnose follicular carcinoma, something very difficult to do intraoperatively. [23] [24] [25] Thus, intraoperative consultation is not practical (and therefore not useful) for cases with a preoperative FNA diagnosis of follicular lesion/neoplasm, and it is not necessary in cases with a definite FNA diagnosis of papillary carcinoma. [23] [24] [25] It can, however, be useful in cases cytologically diagnosed as "suspicious for papillary carcinoma" and in some cases with a cytologic diagnosis of "atypia of undetermined significance." 26, 27 In such instances, at the time of intraoperative consultation the pathologist has the opportunity to analyze both the growth pattern (papillary vs follicular) in the frozen section specimen, and the cytologic features of the lesion with the cytology touch or-better-scrape preparations. The pathologist can thus render a more precise diagnosis to help determining the extent of the operation. It should be noted, however, that the diagnosis of the follicular variant papillary carcinoma in the absence of invasion remains a difficult intraoperative diagnosis even with good cytology smears. 23 The advantages of intraoperative consultation have to be weighed against their obvious drawbacks, including the provisional nature of the assessment, sampling errors, the potential to create artifacts, and the wasting of potentially diagnostic material. These disadvantages are especially significant for small (<1 cm) lesions, which should never be frozen in toto. 23 In addition, intraoperative consultation remains very useful in the determination of the status of surgical margins, metastatic spread, and tissue identification (eg, thyroid vs parathyroid vs lymph node). Thus, although its importance has clearly diminished, it retains a relevant role in specific situations.
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